Epidermal growth factor receptor (EGFR) plays an important role in signaling pathway of the development of breast cancer cells. Since EGFR overexpresses in most breast cancer cells, it is regarded as a biomarker molecule of breast cancer cells. Here we demonstrated a new AFM technique-topography and recognition (TREC) imaging-to simultaneously obtain highly sensitive and specific molecular recognition images and highresolution topographic images of EGFR on single breast cancer cells.
Introduction
Epidermal growth factor receptor (EGFR) is a member of receptor tyrosine kinase (RTK) family of signaling proteins. It was the first mammalian signaling protein to be fully characterized [1] . The activation of EGFR is normally controlled by the interaction with their ligands such as EGF and TGF-α, providing cells with substantial differentiation and growth advantages [2] . However, it has been found that aberrant expression or activation of EGFR appears to be an important factor in both the initiation and the progression of human cancer [3] [4] [5] . For example, in human breast carcinoma (EGFR positive), expression of EGFR was reported to support the existence of tumor cells with aggressive potentials [6] . The expression level of EGFR in metastatic breast tumors was often higher than primary tumors, indicating that EGFR was involved in the process of metastasis [7, 8] . Overexpression and abnormal function of EGFR and its ligands have been found in many different types of human cancers [5] ; this makes it a great prognostic indicator for the development of malignancies. Furthermore, therapeutic strategies have been developed, using small biomolecules (e.g. kinase inhibitors) and large molecules (e.g. monoclonal antibodies) to block the binding of EGFR and its ligands, consequently blocking receptor activation and transduction of post-receptor signals [9, 10] .
Recent study has shown that EGFR functionality can be dependent on its subcellular location and mis-located EGFR may regulate tumor response to therapy [11] . Therefore, localization of EGFR on cancer cells is of great importance. However, it is very challenging to probe the spatial and temporal distribution of specific cell receptors and their signalingrelated molecular actions in molecular cell biology [12, 13] . In recent years, sophisticated technologies have been developed to achieve the identification and localization of those biomolecules in cells. Among them are (1) fluorescence imaging with improved spatial resolution, which can offer the approach to monitor the dynamic information about the localization, distribution of biomolecules and their cellsignaling actions [14, 15] ; (2) electron-dense probes and electron microscopy, which provide nanometer resolution in characterizing and mapping membrane receptors and signaling molecules [16] ; (3) a combination of quantitative mass spectrometry and cryo-electron tomography, providing insights into the distribution of specific protein complexes in cytoplasm [17, 18] . Although these advanced technologies have significantly improved capability of detecting and localizing cell receptors, some limitations still remain: low spatial and temporal resolution, the requirement of physiological and dynamic condition, and low chemical specificity. Few techniques can overcome all these limitations and provide critical measurements of cell membrane receptors.
Since its invention in 1980s, atomic force microscopy (AFM) has become a powerful tool technique for analyzing the morphology of individual molecules at nanometer scale and the forces acting on them with piconewton sensitivity. As to the study of biological samples, AFM presents significant advantages than other microscopic methods since it allows single-molecule level studies of the structure and interaction of complicated biomolecules and cells with nanometer spatial resolution [19] , and it allows samples to be measured in liquid phase (e.g., culture medium), enabling the study of dynamic interactions between biomolecules under physiological condition. Simultaneous Topography and RECognition (TREC) imaging, a new AFM technique based on the high-resolution topographic imaging and single-molecule force measurement [20, 21] , has been developed for receptor imaging with high spatial and temporal resolution, providing exceptional information that is complementary to that obtained by fluorescence and electron microscopy [22] . For example, TREC imaging has been successfully used to visualize, at the first time, the localization and distribution of Na + -K + ATPases in the inner leaflet of cell membranes at singlemolecule level [23] ; by employing TREC, the local organization of Fcγ receptors on single macrophage cell has been determined at singlemolecule level [24] . In addition to cell receptor imaging, TREC imaging technique has also been extensively used to monitor specific biomolecules while they are undergoing biological processes. Wang et al. [20, 25, 26] applied TREC to study the action of human Swi-Snf nucleosome remodeling complex and its interaction with mouse mammary tumor virus promoter during the process of nucleosome remodeling. Besides, they were also able to recognize the glycosylation process of biomolecules by using TREC imaging, and distinguish normal and aberrant antibodies based on their glycosylation [27] . It has been known that BRMS1 is a member of metastasis suppressors, which inhibit metastasis without blocking orthotopic tumor formation in metastatic cascade [28, 29] . Previous studies have shown that the expression of BRMS1 in 435 cells regulates biomechanical properties including cell adhesion and cell elasticity [30] , which probably are induced by reorganization of cytoskeletal structures [31, 32] . Also, it has been reported that BRSM1 regulates the expression of growth factor receptors in 435 cells by differentially modulating their signaling pathway [8] . Aberrant EGFR signaling results in many pathological diseases like neural developmental disorders and cancer [33] . Furthermore, EGFR signaling is mainly up-regulated in breast cancers through activation of NF-κB activity, and BRMS1 has been shown to affect NF-κB activity [34, 35] . To probe this link, we explored whether BRMS1 altered signaling through EGFR. Our previous work [36] has confirmed that BRSM1 down-regulated the expression of EGFR in 435 breast carcinoma cells. Further investigation is needed to address the question whether BRMS1 affects the localized EGFR conformation, which has been shown to be important in changing the binding kinetics of EGFR [37] . TREC imaging presented high specificity, reproducibility, and recognition efficiency at nanoscale. Therefore, TREC imaging method has been applied in order to identify the local binding sites of EGFR on single breast cancer cells.
Molecular recognition using monoclonal antibody (anti-EGFR) tethered scanning tip was converted to high-resolution topography and recognition images. The recognition efficiency was tested in a spatiotemporal manner by introducing EGF as a competing ligand, when conducting TREC imaging of EGFR using antibody-tethered AFM tips. We measured the density and distribution of EGFR on breast cancer cell lines-MDA-MB-435 (435) and 435 transfected with BRMS1 gene (BReast cancer Metastasis Supressor 1 [38, 39] , 435 BRMS1 ). These cell lines provide excellent cell models for EGFR detection as BRMS1 expression has been shown to regulate EGFR expression in these cell lines [8] .
In addition, the advantages of TREC imaging technique in monitoring dynamic changes of cellular biomolecules have been discussed.
Materials and methods

Sample preparation and cell culture
For TREC imaging on mica, epidermal growth factor receptor (EGFR, Life Technologies, Grand Island, NY) solution (0.21 mg/mL, in 0.1X PBS) was dropped onto newly pealed mica surface and left 10 min for adsorption. Rinsed several times with DI water to wash away incompletely adsorbed EGFR and then load mica onto sample plate for recognition imaging. -free PBS (PBS, 0.01 M, pH 7.4, Thermo Scientific). Cell lines were confirmed to be free of mycoplasma contamination using PCR (TaKaRa-Clontech, Mountain View, CA). No antibiotics or antimycotics were used during routine culture. For TREC imaging on cell surface, both living cells and fixed (4% paraformaldehyde) were measured.
AFM tip functionalization
Magnetically coated silicon-nitride AFM tips (Type VI MAC Levers, Agilent Technologies, Chandler, AZ) were functionalized with anti-EGFR antibody using the method reported previously [20] . Briefly, MAC levers were first amino-functionalized with APTES (aminopropyltriethoxysilane, Sigma-Aldrich, St. Louis, MO) under the atmosphere of argon. Subsequently, after rinsing with methylene chloride (Sigma-Aldrich) for three times, MAC levers were attached to NHS-PEG-SS-Pyr (MW 1634, PolyPure, Oslo, Norway) by incubating the tips with the PEG linker for 2 h, with the presence of triethylamine. At the same time, monoclonal antibody to EGFR (anti-EGFR, Life Technologies, Grand Island, NY) was thiolated by reacting with N-succinimidyl 3-(acetylthio) propionate (SATP, Sigma-Aldrich) and subsequently purified in a PD-10 column (GE Healthcare). Finally, the thiolated antibody was conjugated to the AFM tip via the PEG crosslinker by 1 h incubation in deacetylation buffer (hydroxylamine hydrochloride and Triz Base, Sigma Aldrich). Antibody functionalized MAC levers were then rinsed with PBS buffer and stored in 4°C before use. The morphologies of antibody-modified MAC lever tips were imaged by scanning electron microscopy (Hitachi S4000).
AFM recognition imaging
AFM recognition imaging was performed on a PicoPlus AFM system with a PicoTREC attachment unit (Agilent Technologies). Topography and recognition images were recorded simultaneously by using functionalized MAC levers with nominal spring constant of 0.292 N/m. During TREC measurement, a half-amplitude feedback loop was used to measure the unbiased topography. 8-10 nm free oscillation amplitude and~20 kHz driving frequency of the tips were chosen to obtain optimized recognition images. All these parameters were set to make the TREC measurements more easy, robust, and reliable [41] . Image processes (including smooth, contrast adjustment) and the height and width measurements of tested proteins were performed using PicoView software (Agilent Technologies).
The single cell AFM images were taken under contact mode with the instrument setting exactly the same as previously described [42, 43] .
TREC image processing
We employed an adaptive threshold-based segmentation method to find white spots in a topological image and dark spots in a recognition image. We first converted the original color image to a grayscale image. For the recognition image, we also inverted its intensity so the darkest spot turns to the brightest spot and vice versa. After this processing, we aimed to separately find white spots in the grayscale image of the topological image and the inverted grayscale image of the recognition image. To this end, we first computed the average intensity and the standard deviation of the grayscale image. The threshold was then computed as the sum of the average intensity and the standard deviation. For the topological image, we simply marked any position with the pixel intensity larger than the threshold as the white spot. For the recognition image, we similarly marked any position with the pixel intensity larger than the threshold as the dark spot due to the inversion process. Finally, we applied a logical "AND" operation to find the common areas shown up in both white spots of the topological image and dark spots of its paired recognition image. These areas were then overlaid on top of the original topological image to show the white spots in topological image that have been simultaneously recognized in the recognition image as the dark spots.
We implemented the image segmentation method using Matlab 2012(b).
Results and discussion
Principle of TREC and its biological application
Scheme 1 briefly shows the principle of TREC imaging method. The basic principle of TREC imaging is based on small alterations in cantilever oscillation amplitude that occur when tip-tethered antibodies bind to their antigens. When the oscillating antibody-tethered AFM tip scans through the sample, the tethered antibody binds to an antigen on the surface and the upward oscillation of the cantilever is restricted specific antibody-antigen binding force, leading to the decrease in the oscillation amplitude. This reduction of amplitude is sensed by the microscope servo and converted into reduction of the recognition signal (peak voltages). Therefore, a map of recognition signals, together with simultaneously generated topographic image, localizes the antibodyantigen binding events with pairs of bright and dark spots showing on the image.
Applications of TREC technique in biomedical research is certainly an increasingly demanding task. Up to now, TREC imaging method has been applied to visualize quite a few different biomolecule systems, such as biotin-avidin [44, 45] , ligand-receptor [46, 47] , and antibodyantigen interactions [20, 23] . In this study, we utilized TREC imaging to visualize EGFR molecules on complex cell membrane surface, providing a new example of the applications of this methodology in biomedical research. Due to the significant role of EGFR in cancer research, our work appears to inspire an alternative nanoscale instrument technique to primary cancer diagnostics. Furthermore, TREC approach has the potential to study the dynamic activation process of EGFR, which is of great significance, because EGFR can be activated by its specific ligands (e.g. EGF, TGF-α), leading to the growth and spread of tumor [48] .
Functionalization and SEM characterization of AFM MAC lever
Functionalization of AFM MAC lever tips with anti-EGFR antibody was the key point to achieve successful TREC measurements. As shown in Fig. 1a , a procedure with four steps involved has been implemented to conjugate anti-EGFR monoclonal antibody with AFM tip to construct an EGFR-specific AFM nanosensor tip. It should be noted that, in this method, a PEG chain was applied to link the tip and the antibody due to its flexibility that allows for reorientation of the targeting molecule when the tip approaches the surface [49, 50] . The free oscillation amplitude was set comparable to the extended length of the PEG linker (~8 nm) so that antibody on the tip remained bounding to the antigen on the surface during imaging and kept high lateral accuracy as well [50] . The morphologies of bare MAC lever tip (Fig. 1b) and anti-EGFR antibodies modified tip (Fig. 1c) were characterized by scanning electron microscope (SEM). It is clearly seen that the morphology of modified probe was different from bare probe with the presence of "bumps" or "clusters" on the surface. Scheme 1. Schematic illustration of the TREC experiment.
Specificity, efficiency, and reproducibility of TREC
To evaluate the feasibility and efficiency of this TREC imaging method, we first chose mica as the substrate, since it's flat at atomic level, making it suitable to imaging the antibody-antigen interaction. EGFR molecules were adsorbed onto the mica surface through electrostatic interaction. When anti-EGFR antibody-tethered AFM tip approached the surface and scanned through the surface, antibody-antigen recognition events were recorded by simultaneously generated images of the surface topography (Fig. 2a) and recognition (Fig. 2b) signals. "Bright spots" in Fig. 2a represent single molecules or aggregates of EGFR, and the corresponding "dark spots" in Fig. 2b represent the recognition events of EGFR. The numbers and positions of "bright spots" in topography image match those "dark spots" in recognition image, indicating the antibody-antigen recognition occurred. These events were originated from the tip-tethered antibody binds to antigens, restricting the tip to oscillate upwards and leading to the reduction of the oscillation amplitude. To test the specificity of the recognition process, an anti-EGFR antibody solution (20 μg/mL) was injected via a liquid flow cell to block the interaction between tip-tethered anti-EGFR and EGFR on the surface. After 10 min adsorption, "dark spots" on recognition image were disappeared when conducting scan on the same location (Fig. 2c) . The inset image in Fig. 2c was the corresponding topography image after block control experiment, which showed similar feature pattern but a small shift in the feature locations. The location shift was due to interference of the system caused by injection of free anti-EGFR solution. Crosssection line profiling analysis along the recognition events (red and green lines on Fig. 2a, b, and c) showed that before free anti-EGFR blocking, there were significant recognition signals (Fig. 2e) observed by the two pairs of matching peaks in both topography (Fig. 2d) and recognition ( Fig. 2e) images; however, as blocked by excess specific antibody, recognition signals of the antigens were dramatically decreased (Fig. 2c, f) . Furthermore, as a control experiment, bare tip was employed to scan EGFR on mica surface (Fig. S1a) . Apparent "bright spots" features on topography image were presented, while no features were shown on recognition image. After a BSA solution (50 μg/mL) was injected and let adsorbed for 10 min, recognition events still appeared as antibodytethered tip scanning on the surface (Fig.S1b) , showing that nonspecific protein-protein interaction wouldn't affect the recognition. All these results indicate the recognition events were highly specific-only EGFR molecules were recognized when sensing with anti-EGFR antibody-tethered AFM tip.
Efficiency of the EGFR recognition was also tested on mica. As shown in Fig. 3 , bright spots in topography image and dark spots in recognition image were labeled by a pair of green dots, representing a pair of recognition events took place. In this typical image, almost all features (45 out of 47) in topography image were recognized, indicating perfect recognition efficiency of this TREC imaging method to detect EGFR through specific antibody-antigen interaction. In addition, to test the reproducibility of recognition, the sample was rescanned at the same position. Only a few changes labeled with blue dots and circles had happened in the rescan of the same area, showing generally high reproducibility of the recognition.
EGF effects on TREC imaging of EGFR
EGF acts as a competing ligand that may affect the recognition of EGFR by AFM tip-tethered anti-EGFR. To investigate how EGF affects the antibody-antigen recognition between EGFR and its antibody, we applied TREC imaging to measure EGFR on mica with and without EGF presence. As shown in Fig. 4 , when EGFR was presented alone on the mica surface (Fig. 4a) , the recognition events (green) occurred or overlapped at the most of the "bright spots" area, indicating the high recognition efficiency between the tip-tethered antibody and the EGFR; however, the TREC image scanned at 10 min after EGF (20 μg/mL) introduction (Fig. 4b) showed only reduced level of recognition, revealing the incomplete blocking by EGF on the binding sites between EGFR and its antibody. Analyses of multiple images show that the average recognition percentage dropped from 84.3 ± 3.4% (n = 3) to 57.4 ± 13.53% (n = 3) when EGF is presented as a competitor (Fig. 4c) . Comparing the partial block by EGF with the complete block by anti-EGFR antibody (Fig. 2c) , it is suggested that, under this experimental condition, the binding affinity of EGFR to anti-EGFR antibody is higher for than of EGFR to EGF. Measurements of the binding kinetics are important in understanding the activation mechanism of EGFR. Previous studies have shown that the binding kinetics between EGF and EGFR significantly vary under different EGFR conformation in cells [37, 51, 52] . However, to our knowledge, there is no study comparing the binding affinity between the anti-EGFR antibody to EGFR and EGF to EGFR, which might be valuable in order to develop antibody-based cancer therapy through EGFR, and worth further investigation.
TREC imaging of EGFR on 435 and 435 BRMS1 cells
After evaluation of imaging EGFR on mica, it is necessary to assess the performance of this EGFR-modified AFM-tip nanosensor in imaging EGFR on breast cancer cell surfaces. Morphologies of fixed single metastatic 435 and non-metastatic 435 BRMS1 cells were visualized by contact mode AFM, and their morphologies have been shown to be very different ( Fig. 5a-d) . Typical topography and deflection images of 435 cells are shown in Fig. 5a and c, respectively. The shape of 435 cells was observed to be round-like, which is typical for metastatic cancer cells [30, 53] . Nevertheless, as shown in Fig. 5b and d, the 435 BRMS1 cell has an elongated morphology comparing with the 435 cell. Changes in cell morphology caused by BRMS1 transfection have also been previously reported [30] . While features like chemosensitivity were not significantly affected by BRMS1 [54] , the BRMS1 did regulate the expression of several cellular receptors, such as EGFR [8, 36] . TREC imaging method was carried out to further probe the local distribution of EGFR molecules on the membrane surface of fixed 435 and 435 BRMS1 cells. Comparing with the TREC images on mica surface, the images on cells were less distinct with the distribution of EGFR due to the complexity of cell membrane surface. We then applied an image segmentation method to find out the corresponding "recognition sites" by comparing topography and recognition images, and superimpose the recognitions sites (green) onto corresponding topography images taken from central area of the fixed 435 (Fig. 5e ) and 435 BRMS1 cells (Fig. 5f ). It is found that EGFR heterogeneously distributed on both 435 and 435 BRMS1 cells and tended to form domains with a scale of tens of nanometers. However, this observation was obtained on the fixed cells, which may not reflect the real EGFR distribution on living cells. In addition, it is also required to conduct living cell measurements in order to image the dynamic changes of the cell receptors. Fig. 6a shows the recognition of EGFR in living 435 cells using TREC imaging technique. Comparing with the fixed 435 cell, the living 435 cell exhibits a more uniform EGFR local distribution, and small domains of about 10 nm in scale were mainly observed. The presence of recognition events was also confirmed by the corresponding peaks through cross-session profiling curves, though with reduced amplitudes, occurred in the line profiles along the images (Fig. 6b) . The smallest recognition events showing the binding sites of EGFR molecules were nanometer scale (~5 nm), which is comparative to the size of single molecule of EGFR [55] , indicating that TREC is able to achieve analysis of biomolecules at single-molecule level. However, since TREC imaging is based on amplitude measurements, it is unable to quantitatively confirm the single-molecule level recognition, which is usually measured by AFM-based single-molecule force spectroscopy [21, 56] . Even though, TREC provides nanoscale imaging resolution, making it applicable to monitor the conformational changes of cell surface receptors during biological processes. Furthermore, the whole imaging process was done within several minutes, which means TREC imaging has potential to in situ monitor many biological processes such as the activation of EGFR molecules by their specific ligands (e.g. EGF, TGF-α). 
Conclusions
This work reported an AFM-based topography and recognition (TREC) imaging technique for targeting and imaging cancer biomarker EGFR in single human breast cancer cells. It achieved high specificity, reproducibility, and efficiency in EGFR recognition by using an antibody-tethered AFM tip. By imaging EGFR molecules before and after EGF introduction. It demonstrated the potential to monitor the ligand-receptor interaction at molecular level. Furthermore, the TREC imaging technique successfully probed the heterogeneous distribution of EGFR, with nanoscale spatial resolution, on the plasma membrane of single breast cancer cells, under the influence of Breast cancer Metastasis Suppressor 1 (BRMS1). This TREC imaging technique can be used as a powerful imaging tool to study different cell surface receptors at molecular level, which is important and still challenging, in physiological and pathological studies.
